HIV-1 infection remains a major public health problem, with an estimated 38.4 million people living with HIV and 1.5 million new HIV infections reported worldwide in 2021. The risk of HIV infection ...
A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, USA, ...
Oral HIV pre-exposure prophylaxis (PrEP) is highly effective for preventing HIV. Several different developments in the US either threaten to increase or promise to decrease PrEP out-of-pocket costs ...
If you have unprotected sex or you've got more than one partner, pre-exposure prophylaxis (PrEP) is your best defense against HIV, the virus that causes AIDS. When you take PrEP the right way, it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results